%0 Journal Article
%A Mai, Elias K
%A Nogai, Axel
%A Lokhorst, Henk M
%A van der Holt, Bronno
%A Zweegman, Sonja
%A Weisel, Katja C
%A Croockewit, Sandra
%A Jauch, Anna
%A Hillengass, Jens
%A Stevens-Kroef, Marian
%A Raab, Marc S
%A Broijl, Annemiek
%A Bos, Gerard M J
%A Brossart, Peter
%A Ypma, Paula
%A Hanoun, Christine
%A Bertsch, Uta
%A Hielscher, Thomas
%A Salwender, Hans J
%A Scheid, Christoph
%A Goldschmidt, Hartmut
%A Sonneveld, Pieter
%T Bortezomib before and after high-dose therapy in transplant-eligible patients with newly diagnosed multiple myeloma: Long-term overall survival after more than 10 years of follow-up from the phase III HOVON-65/GMMG-HD4 trial.
%J HemaSphere
%V 8
%N 11
%@ 2572-9241
%C [Philadelphia, Pennsylvania]
%I Wolters Kluwer Health
%M DKFZ-2024-02389
%P e70052
%D 2024
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:39569355
%2 pmc:PMC11577299
%R 10.1002/hem3.70052
%U https://inrepo02.dkfz.de/record/294645